IL3 and myeloid sarcoma: IL-3 was shown to exacerbate EAE (56) and to be upregulated in MS lesions (57), whereas another study describes it to be a marker of encephalitogenic T helper 1 (Th1) and Th17 cells but redundant for the severeness of EAE symptoms (58).